Endonovo Therapeutics Granted Trademarks for WoundPulse and OrthoHalo
March 22, 2019 08:00 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, March 22, 2019 (GLOBE NEWSWIRE) -- March 22, 2019 -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive...
Endonovo Therapeutics Partners with SunMED Medical Systems
March 20, 2019 08:00 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, March 20, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), Alan Collier, Endonovo’s Chief Executive Officer, stated "We are...
International Stem Cell Corporation Publishes Successful Results in Traumatic Brain Injury
February 13, 2019 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Feb. 13, 2019 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
Endonovo Therapeutics Enters into $10 million Common Stock Purchase Agreement with Azure Capital
January 03, 2019 11:10 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapeutic...
Endonovo Therapeutics Announces Receipt of Notice of Allowance from the United States Patent and Trademark Office
December 18, 2018 09:25 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapies...
Global Traumatic Brain Injuries Treatment Market, Improving Quality of Life and Boosting the Healthcare Business is Expected to Reach USD 156.8 Billion by 2024
November 20, 2018 06:11 ET
|
Energias Market Research
NEW YORK, Nov. 20, 2018 (GLOBE NEWSWIRE) -- The global traumatic brain injuries treatment market is expected to grow steadily from USD 112.6 billion in 2017 to USD 156.8 billion in 2024, at a CAGR...
Endonovo Therapeutics Announces Complimentary New Product
November 08, 2018 10:00 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapies,...
Endonovo Therapeutics Provides Update on Liver Study
October 22, 2018 10:00 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive Electroceutical™ therapies,...
Endonovo Therapeutics Announces Enrollment of First Patient in Clinical Study at the University of New Mexico for Treating Traumatic Brain Injury Using Its Electroceutical™ Therapy
June 14, 2018 08:30 ET
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, June 14, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of Electroceutical™ Therapies, today...
Story of Traumatic Brain Injury Wins #IAmInvisibleNoMore Video Contest
May 04, 2018 17:10 ET
|
Allsup
Belleville, Illinois, May 04, 2018 (GLOBE NEWSWIRE) -- The Invisible Disabilities Association (IDA), an organization dedicated to raising worldwide awareness of invisible disabilities, and Allsup,...